1. Home
  2. AAME vs BCTX Comparison

AAME vs BCTX Comparison

Compare AAME & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$1.39

Market Cap

34.3M

Sector

Finance

ML Signal

HOLD

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.22

Market Cap

36.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
BCTX
Founded
1968
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
36.6M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
AAME
BCTX
Price
$1.39
$4.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $40.00
AVG Volume (30 Days)
61.9K
★ 157.6K
Earning Date
05-12-2026
06-15-2026
Dividend Yield
★ 0.81%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.22
N/A
Revenue
★ $188,227,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
$5.95
★ N/A
Revenue Growth
★ 0.77
N/A
52 Week Low
$1.25
$2.60
52 Week High
$3.24
$14.68

Technical Indicators

Market Signals
Indicator
AAME
BCTX
Relative Strength Index (RSI) 51.31 59.07
Support Level $1.26 $3.66
Resistance Level $1.62 $4.51
Average True Range (ATR) 0.06 0.22
MACD 0.02 0.04
Stochastic Oscillator 86.66 64.79

Price Performance

Historical Comparison
AAME
BCTX

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: